BPC-157: Uses, Dosage Ranges, Safety & Legal Status (2026)
BPC-157 is a synthetic 15–amino-acid peptide studied mostly in animals for soft-tissue, tendon, and gut healing. It is not approved for human use, is banned in sport, and is sold only as a "research chemical." Doses commonly reported in the community sit around 200–500 mcg per day by subcutaneous injection — but there is no clinically established safe human dose, and the long-term effects are unknown.
Editorially reviewed · Last updated June 2026 · This article is educational and is not medical advice. Talk to a licensed clinician before using any peptide.
What is BPC-157?
BPC-157 ("Body Protection Compound-157") is a lab-made peptide based on a sequence found in human gastric juice. It's 15 amino acids long, which keeps it in the "peptide" class the FDA defines as 40 amino acids or fewer.
In animal studies it's been linked to faster healing of tendon, ligament, muscle, bone, and gut tissue, largely through angiogenesis (new blood-vessel growth) and effects on growth-factor pathways. That same mechanism is also the source of its biggest open safety question (more below).
The honest summary: the rodent data is genuinely interesting, but human evidence is thin. A few early-stage human studies exist (including IBD work under the name PL-14736 and a small IV safety pilot), but there are no large, completed, published human trials establishing that it works or that it's safe at any dose.
What people use BPC-157 for
People most commonly report using BPC-157 for:
- Tendon, ligament, and muscle injury recovery
- Joint pain and post-surgical healing
- Gut issues (it's often taken orally for this)
- General "systemic healing" and inflammation
- Recovery stacks with TB-500, which is dosed on a weekly milligram schedule rather than daily micrograms
It's important to separate reported use from proven use. Most of these applications rest on animal research and personal anecdote, not human clinical trials. Anyone telling you BPC-157 is a confirmed treatment for an injury is going beyond what the evidence currently supports.
BPC-157 dosage: commonly reported ranges
The figures below are commonly reported in community use and extrapolated from animal research. They are not a recommendation, a protocol, or a verified safe dose. Dosing varies widely because there's no human standard, body weight and goals differ, and product purity is inconsistent across sources.
| Approach | Commonly reported range | Notes |
|---|---|---|
| Systemic (subcutaneous) | ~250–500 mcg, once or twice daily | The most commonly described route |
| Lower-end systemic | ~200–300 mcg/day | Often used to "start low" |
| Local injection near an injury | varies | Some users inject near the affected site; no evidence this beats systemic |
| Oral (stabilized/arginate salt) | ~250–500 mcg/day | Popular for gut goals; oral bioavailability is debated |
| Typical reported cycle length | ~2–6 weeks (sometimes up to 8) | Often cycled off afterward |
Two things worth stating plainly:
- Lower is not automatically safer or higher automatically better. There's no dose-response data in humans to anchor any of this.
- The dose on the vial is only as accurate as the source. Underdosed, overdosed, and contaminated "research chemical" vials are common — see sourcing below.
How BPC-157 is reconstituted
Injectable BPC-157 ships as a freeze-dried powder that's mixed with bacteriostatic water before use. The number of "units" drawn into an insulin syringe depends entirely on how much water you add to the vial, which is why dosing errors are common. Use our peptide calculator to check draw volumes against your syringe size and to catch unit mistakes (mg versus mcg).
People who use it typically refrigerate the reconstituted vial, protect it from light, and use sterile technique to avoid infection. If you can't measure and reconstitute accurately and sterilely, that alone is a reason not to inject.
BPC-157 side effects and safety
Because there are no large human safety studies, the real answer to "is it safe?" is we don't know. What's reported:
- Anecdotally reported, usually mild: injection-site irritation, fatigue, nausea, headache, dizziness, lightheadedness.
- The major open question — cancer risk.BPC-157 promotes blood-vessel growth, and tumors also rely on blood-vessel growth. Researchers have flagged a theoretical concern that it could promote existing or undiagnosed cancers. This is unproven either way, but it's why people with a personal or family history of cancer are widely advised to avoid it.
- Unknown long-term effects. No one has good data on what months or years of use does.
- Contamination and dosing risk from unregulated sourcing, which is arguably the most realistic near-term danger.
Stop and seek medical care if you notice signs of infection at an injection site (spreading redness, heat, pus, fever), chest pain, severe allergic reaction, or any unusual lump or growth.
Is BPC-157 legal in 2026?
BPC-157 sits in a legal gray zone, and the situation is actively changing:
- It is not approved by the FDA for any human use.
- The FDA currently classifies it as a Category 2 ("substance with safety concerns") bulk drug substance, which means it is prohibited from being compounded by licensed pharmacies for human use.
- It has been on the World Anti-Doping Agency's Prohibited List (class S0, non-approved substances) and is also on the U.S. Department of Defense's Prohibited Dietary Supplement Ingredients list. WADA banned it in 2022.
- Most products are sold labeled "Research Use Only" or "research chemical, not for human consumption" — that label is a liability shield for the seller, not a safety clearance.
- This may change soon: the FDA's Pharmacy Compounding Advisory Committee is scheduled to review BPC-157 (free base and acetate forms) on July 23–24, 2026. The active public docket is FDA-2025-N-6895. The outcome could move BPC-157 toward or further away from legal compounding.
For most individuals, possession isn't separately criminalized, but selling it for human use draws FDA enforcement, and using it makes you personally responsible for an unapproved, untested product. Competitive athletes should treat it as a guaranteed doping violation.
How to evaluate BPC-157 sourcing and quality
If someone is going to use a research peptide despite the above, sourcing is where the most avoidable harm lives. What to look for:
- A recent, batch-specific Certificate of Analysis (COA) with HPLC purity (ideally ≥98%) and mass-spec identity confirmation.
- Independent third-party testing, not just the vendor's own lab.
- Clear handling/storage info and sterile, properly sealed vials.
- Realistic claims — any vendor promising it "cures" injuries or is "FDA-approved" is lying.
No COA, vague sourcing, or suspiciously cheap pricing are all reasons to walk away.
Who should not use BPC-157
- Anyone pregnant or breastfeeding
- Anyone with a personal or family history of cancer (angiogenesis concern)
- Competitive or tested athletes (WADA-banned)
- Anyone who can't get clinical oversight or verify their source
- Minors
References
- FDA — Pharmacy Compounding Advisory Committee meeting, July 23–24, 2026 (docket FDA-2025-N-6895)
- FDA — 503A bulk drug substances / Category 2 classification
- World Anti-Doping Agency — Prohibited List (S0)
- DoD Operation Supplement Safety (OPSS) — BPC-157 advisory
- Józwiak et al., "Multifunctionality and Possible Medical Application of the BPC-157 Peptide," Pharmaceuticals (2025)
← All dosing protocolsResourcesPeptide calculatorEU shop rankings
Frequently asked questions
What is a typical BPC-157 dosage?
Commonly reported ranges are roughly 200–500 mcg per day, usually by subcutaneous injection, in cycles of a few weeks. This reflects community use and animal-study extrapolation, not a clinically validated or officially recommended human dose.
Is BPC-157 safe?
There's no large human safety data, so it can't honestly be called safe. Reported side effects are usually mild, but the long-term effects are unknown and there's a theoretical concern that it could promote tumor growth.
Is BPC-157 legal in 2026?
It's not FDA-approved and is a Category 2 substance prohibited from compounding for human use. It's sold only as a "research chemical." The FDA is reviewing it in July 2026, so its status may change.
Is BPC-157 banned in sport?
Yes. WADA placed it on its Prohibited List in 2022, and it's on the DoD's prohibited list. Tested athletes and service members should not use it.
Oral or injectable BPC-157 — which is better?
Injectable is the more-studied route for systemic effects; oral (stabilized salt) is popular for gut goals, though its absorption is debated. Neither has strong human comparison data.
Does BPC-157 cause cancer?
There's no human evidence that it does. Because it promotes blood-vessel growth, which tumors also depend on, researchers have raised it as a theoretical risk — which is why people with cancer history are advised to avoid it.
How should BPC-157 be stored?
Lyophilized powder is typically kept cold and out of light; once reconstituted with bacteriostatic water it's refrigerated and used within a limited window. Follow the source's batch-specific guidance.